Anti-Carcinoembryonic Antigen (CEA)

Carcinoembryonic antigen (CEA) is synthesized during development in the fetal gut, and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Anti-CEA is reportedly useful in identifying the origin of various metastatic adenocarcinomas and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Applications: Suitable for use in ELISA. Other applications not tested. Recommended Dilutions: Optimal dilutions to be determined by the researcher. Matched Pair: Suitable for use as the capture or solid phase antibody. Matched to C1299-87E, C1299-87F or C1299-87U, C1299-87H as the detection or conjugate (label) antibody., Also suitable for use as the detection or conjugate (label) antibody. Matched to C1299-87F, C1299-87H, C1299-87U as the capture or solid phase antibody. Source: Ascites, Affinity Constant: 1x10e9L/mole, Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.